Myocardial infarction test kit cTnI/Myo/CK-MB

myoglobincTnIcreatine kinase

5 tests/box, 25 tests/box, 40 tests/box, 100 tests/box Certificates: CE, ISO13485, ISO9001 Matching Equipments: Solid Phase Fluorescence Immunoassay System Manufactured by Guangzhou KOFA Biotechnology Co.,Ltd. Intended Use: This reagent kit is base on fluorescent chromatographic technology, supporting the quantitative rapid test of Myo/cTnI/CK-MB level in the serum/plasma. The combined testing of Myo/cTnI/CK-MB is used to diagnose myocardial injury and infarction. The advantages of KOFA 3 In 1 (Myo/cTnI/ CK-MB): 1. Advanced fluoroimmunoassay quantitative testing platform, make accurate and quantitative rapid test of Myo/cTnI/CK-MB level available 2. Low cost and rapid test, can get the quantitative and reliable results in 15 minutes, shorten the testing turnaround time. 3. The testing results from KOFA Myo/cTnI/CK-MB has good correlation with that of Roche Diagnostics (compared with thousands of samples). 4. Simple operation and rapid test, can meet the need of various departments. 5. The combined testing of Myo, cTnI and CK-MB is more convenient, accurate and efficient than single testing items, making the patients well-treated in the shorter time. Applicable Departments: Departments of cardiology, surgery, geriatrics, respiratory, pediatrics, obstetrics, emergency ward and ICU.